# Enliven Therapeutics, Inc. (ELVN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ELVN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -23.63M | $ -19.29M | $ 302.0K | $ 453.37M |
| 2025 | $ 0 | $ -106.17M | $ -72.14M | $ 399.0K | $ 459.60M |
| 2024 | $ 0 | $ -93.57M | $ -76.98M | $ 0 | $ 309.85M |
| 2023 | $ 0 | $ -77.40M | $ -66.41M | $ 335.0K | $ 245.91M |
| 2022 | $ 0 | $ -42.07M | $ -36.52M | $ 323.0K | $ -76.83M |
| 2021 | $ 0 | $ -54.03M | $ -55.61M | $ 159.0K | $ 106.86M |
| 2020 | $ 0 | $ -52.69M | $ -47.67M | $ 0 | $ 84.44M |
| 2019 | $ 0 | $ -30.28M | $ -28.42M | $ 0 | $ 28.92M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.03 |
| Current Ratio | 40.32 |

## Other views

- [Metrics](https://sponda.capital/en/ELVN.md)
- [Charts](https://sponda.capital/en/ELVN/charts.md)
- [Compare](https://sponda.capital/en/ELVN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.